Anaesthetics, Pain Medicine and Intensive Care, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital, London, UK.
Brunel University London, Uxbridge, Middlesex, UK.
EBioMedicine. 2018 Feb;28:31-42. doi: 10.1016/j.ebiom.2018.01.025. Epub 2018 Feb 2.
Ischemia-reperfusion injury (IRI) during renal transplantation often initiates non-specific inflammatory responses that can result in the loss of kidney graft viability. However, the long-term consequence of IRI on renal grafts survival is uncertain. Here we review clinical evidence and laboratory studies, and elucidate the association between early IRI and later graft loss. Our critical analysis of previous publications indicates that early IRI does contribute to later graft loss through reduction of renal functional mass, graft vascular injury, and chronic hypoxia, as well as subsequent fibrosis. IRI is also known to induce kidney allograft dysfunction and acute rejection, reducing graft survival. Therefore, attempts have been made to substitute traditional preserving solutions with novel agents, yielding promising results.
肾移植过程中的缺血再灌注损伤(IRI)常引发非特异性炎症反应,导致移植物失活。然而,IRI 对移植物长期存活的影响尚不确定。本文综述了临床证据和实验室研究,阐明了早期 IRI 与晚期移植物丢失之间的关联。我们对以往文献的批判性分析表明,早期 IRI 通过减少肾脏功能单位、移植物血管损伤和慢性缺氧以及随后的纤维化,确实会导致晚期移植物丢失。IRI 还已知会导致肾移植功能障碍和急性排斥反应,从而降低移植物存活率。因此,人们尝试用新型药物替代传统的保存液,取得了有希望的结果。